GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better Prognosis in Intraductal Pancreatic Mucinous Neoplasms

被引:11
作者
Gaujoux, Sebastien [1 ,2 ,3 ]
Parvanescu, Alina [1 ,4 ]
Cesaretti, Manuella [1 ]
Silve, Caroline [5 ,6 ,7 ]
Bieche, Ivan [8 ]
Rebours, Vinciane [4 ,9 ,10 ]
Levy, Philippe [4 ,9 ,10 ]
Sauvanet, Alain [1 ,10 ]
Cros, Jerome [4 ,11 ]
机构
[1] Hop Beaujon, AP HP, PMAD, Dept Hepatopancreatobiliary Surg, Clichy, France
[2] Univ Paris 05, Paris, France
[3] Inst Cochin, CNRS, UMR8104, INSERM,U1016, Paris, France
[4] Ctr Rech Biomed Bichat Beaujon CRI, INSERM, U1149, Clichy, France
[5] Grp Hosp Paris Sud, INSERM, U986, Le Kremlin Bicetre, France
[6] Hop Cochin, Serv Genet & Biol Mol, Paris, France
[7] Filiere OSCAR, Ctr Reference Malad Rares Metab Calcium & Phospho, Le Kremlin Bicetre, France
[8] Inst Curie, Unite Pharmagogen, Paris, France
[9] Hop Beaujon, AP HP, PMAD, Dept Pancreatol Gastroenterol, Clichy, France
[10] Univ Paris Diderot, Paris, France
[11] Hop Beaujon, AP HP, Dept Pathol, Clichy, France
关键词
INTERNATIONAL CONSENSUS GUIDELINES; ACTIVATING MUTATIONS; CYSTIC NEOPLASMS; IPMN; CLASSIFICATION; MANAGEMENT; PROGRESSION; BIOMARKERS; CARCINOMA; LESIONS;
D O I
10.1245/s10434-019-07389-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe management of intraductal papillary mucinous neoplasms (IPMNs) is mainly based on imaging features and clinical symptoms, and remains challenging.ObjectiveThe aim of this study was to assess GNAS, RAS family (KRAS, NRAS and HRAS), BRAF, and PIK3CA mutation status in resected IPMNs and correlate it with clinicopathological characteristics and patient survival.MethodsOverall, 149 consecutive unselected patients who underwent pancreatectomy for IPMNs were included. After dissection from formalin-fixed and paraffin-embedded tumors, GNAS mutational screening was assessed by allelic discrimination using Taqman((R)) probes and confirmed by SNaPshot analysis. RAS family, BRAF, and PIK3CA mutational screening was assessed by high resolution melt and Sanger sequencing.ResultsGastric- and intestinal-type IPMNs were the most frequent lesions (52% and 41%, respectively). Intestinal-type IPMNs were more frequently associated high-grade dysplasia (49%) and were the only IPMNs associated with colloid-type carcinoma. All pancreatobiliary IPMNs were invasive lesions, located in the main pancreatic duct. GNAS-activating mutations were strongly associated with the intestinal phenotype (p<10(-4)), while RAS pathway mutations were not associated with any particular phenotype. Mutations within other members of the epidermal growth factor receptor (EGFR) pathway were very rare (2%). GNAS-mutated IPMNs were rarely invasive (11%) and almost exclusively (83%) of the colloid type. For invasive lesions, multivariate analyses determined that only node negativity was associated with improved cancer-specific survival, but, in univariate analysis, GNAS mutation was associated with prolonged survival.ConclusionIn patients selected for surgery, GNAS mutation analysis and tumor phenotype can help to better predict patient prognosis. In the near future, a more precise mutational analysis of IPMNs might help to better tailor their management.
引用
收藏
页码:2640 / 2650
页数:11
相关论文
共 38 条
  • [1] Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms - Delineation of an "Intestinal" pathway of carcinogenesis in the pancreas
    Adsay, NV
    Merati, K
    Basturk, O
    Iacobuzio-Donahue, C
    Levi, E
    Cheng, JD
    Sarkar, FH
    Hruban, RH
    Klimstra, DS
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (07) : 839 - 848
  • [2] A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas
    Basturk, Olca
    Hong, Seung-Mo
    Wood, Laura D.
    Adsay, N. Volkan
    Albores-Saavedra, Jorge
    Biankin, Andrew V.
    Brosens, Lodewijk A. A.
    Fukushima, Noriyoshi
    Goggins, Michael
    Hruban, Ralph H.
    Kato, Yo
    Klimstra, David S.
    Kloeppel, Guenter
    Krasinskas, Alyssa
    Longnecker, Daniel S.
    Matthaei, Hanno
    Offerhaus, G. Johan A.
    Shimizu, Michio
    Takaori, Kyoichi
    Terris, Benoit
    Yachida, Shinichi
    Esposito, Irene
    Furukawa, Toru
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (12) : 1730 - 1741
  • [3] Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas
    Berger, Andreas W.
    Schwerdel, Daniel
    Costa, Ivan G.
    Hackert, Thilo
    Strobel, Oliver
    Lam, Sandra
    Barth, Thomas F.
    Schroeppel, Bernd
    Meining, Alexander
    Buechler, Markus W.
    Zenke, Martin
    Hermann, Patrick C.
    Seufferlein, Thomas
    Kleger, Alexander
    [J]. GASTROENTEROLOGY, 2016, 151 (02) : 267 - 270
  • [4] Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection
    Cacheux, Wulfran
    Rouleau, Etienne
    Briaux, Adrien
    Tsantoulis, Petros
    Mariani, Pascale
    Richard-Molard, Marion
    Buecher, Bruno
    Dangles-Marie, Virginie
    Richon, Sophie
    Lazartigues, Julien
    Jeannot, Emmanuelle
    Farkhondeh, Fereshteh
    Sastre-Garau, Xavier
    de La Rochefordiere, Anne
    Labib, Alain
    Falcou, Marie-Christine
    Stevens, Denise
    Roth, Arnaud
    Roman-Roman, Sergio
    Mitry, Emmanuel
    Bieche, Ivan
    Lievre, Astrid
    [J]. BRITISH JOURNAL OF CANCER, 2016, 114 (12) : 1387 - 1394
  • [5] Incidental pancreatic cystic neoplasms in an asymptomatic healthy population of 21,745 individuals Large-scale, single-center cohort study
    Chang, Ye Rim
    Park, Joo Kyung
    Jang, Jin-Young
    Kwon, Wooil
    Yoon, Jeong Hee
    Kim, Sun-Whe
    [J]. MEDICINE, 2016, 95 (51) : e5535
  • [6] Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis
    Crippa, Stefano
    Bassi, Claudio
    Salvia, Roberto
    Malleo, Giuseppe
    Marchegiani, Giovanni
    Rebours, Vinciane
    Levy, Philippe
    Partelli, Stefano
    Suleiman, Shadeah L.
    Banks, Peter A.
    Ahmed, Nazir
    Chari, Suresh T.
    Fernandez-del Castillo, Carlos
    Falconi, Massimo
    [J]. GUT, 2017, 66 (03) : 495 - 506
  • [7] Clinicopathological Correlates of Activating GNAS Mutations in Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
    Dal Molin, Marco
    Matthaei, Hanno
    Wu, Jian
    Blackford, Amanda
    Debeljak, Marija
    Rezaee, Neda
    Wolfgang, Christopher L.
    Butturini, Giovanni
    Salvia, Roberto
    Bassi, Claudio
    Goggins, Michael G.
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Eshleman, James R.
    Hruban, Ralph H.
    Maitra, Anirban
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (12) : 3802 - 3808
  • [8] European evidence-based guidelines on pancreatic cystic neoplasms
    Del Chiaro, Marco
    Besselink, Marc G.
    Scholten, Lianne
    Bruno, Marco J.
    Cahen, Djuna L.
    Gress, Thomas M.
    van Hooft, Jeanin E.
    Lerch, Markus M.
    Mayerle, Julia
    Hackert, Thilo
    Satoi, Sohei
    Zerbi, Alessandro
    Cunningham, David
    De Angelis, Claudio
    Giovanni, Marc
    de-Madaria, Enrique
    Hegyi, Peter
    Rosendahl, Jonas
    Friess, Helmut
    Manfredi, Riccardo
    Levy, Philippe
    Real, Francisco X.
    Sauvanet, Alain
    Abu Hilal, Mohammed
    Marchegiani, Giovanni
    Esposito, Irene
    Ghaneh, Paula
    Engelbrecht, Marc R. W.
    Fockens, Paul
    van Huijgevoort, Nadine C. M.
    Wolfgang, Christopher
    Bassi, Claudio
    Gubergrits, Natalya B.
    Verbeke, Caroline
    Kloppel, Gunter
    Scarpa, Aldo
    Zamboni, Giuseppe
    Lennon, Anne Marie
    Sund, Malin
    Kartalis, Nikolaos
    Grenacher, Lars
    Falconi, Massimo
    Arnelo, Urban
    Kopchak, Kostantin V.
    Oppong, Kofi
    McKay, Colin
    Hauge, Truls
    Conlon, Kevin
    Adham, Mustapha
    Ceyhan, Guralp O.
    [J]. GUT, 2018, 67 (05) : 789 - 804
  • [9] Pathohistological Subtype Predicts Survival in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
    Distler, Marius
    Kersting, Stephan
    Niedergethmann, Marco
    Aust, Daniela E.
    Franz, Melanie
    Rueckert, Felix
    Ehehalt, Florian
    Pilarsky, Christian
    Post, Stefan
    Saeger, Hans-Detlev
    Gruetzmann, Robert
    [J]. ANNALS OF SURGERY, 2013, 258 (02) : 324 - 330
  • [10] Quality assessment of the guidelines on cystic neoplasms of the pancreas
    Falconi, Massimo
    Crippa, Stefano
    Chari, Suresh
    Conlon, Kevin
    Kim, Sun-Whe
    Levy, Philippe
    Tanaka, Masao
    Werner, Jens
    Wolfgang, Christopher L.
    Pezzilli, Raffaele
    Castillo, Carlos Fernandez-del
    [J]. PANCREATOLOGY, 2015, 15 (05) : 463 - 469